<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>CRISPR-Based Enhancement of Transformation Competence in Recalcitrant Elite Maize Lines — Lab Packet</title>
<style>  * { box-sizing: border-box; }
  body { margin: 0; font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, sans-serif; background: #f5f5f5; color: #111827; line-height: 1.5; }
  .container { max-width: 900px; margin: 0 auto; padding: 24px 16px 40px; }
  h1 { margin: 0 0 6px; font-size: 24px; }
  .subtitle { color: #4b5563; margin: 0 0 16px; font-size: 14px; }
  .nav { display: flex; gap: 10px; flex-wrap: wrap; margin-bottom: 20px; }
  a { color: #9b9b94; text-decoration: none; }
  a:hover { color: #6b6b64; text-decoration: underline; }
  .nav a { display: inline-block; padding: 6px 12px; border: 1px solid #d1d5db; border-radius: 7px; background: #fff; color: #1f2937; font-size: 13px; text-decoration: none; }
  .nav a:hover { border-color: #9b9b94; color: #6b6b64; text-decoration: none; }
  .meta { display: flex; gap: 8px; flex-wrap: wrap; margin-bottom: 16px; }
  .tag { display: inline-block; padding: 2px 8px; border-radius: 999px; font-size: 11px; font-weight: 600; }
  .tag-go { background: #dcfce7; color: #166534; }
  .tag-score { background: #dbeafe; color: #1e40af; }
  .tag-cost { background: #ecfeff; color: #155e75; }
  section { background: #fff; border: 1px solid #e5e7eb; border-radius: 10px; padding: 16px; margin-bottom: 12px; }
  section h2 { margin: 0 0 8px; font-size: 15px; text-transform: uppercase; letter-spacing: 0.5px; color: #374151; }
  section p { margin: 0 0 6px; font-size: 14px; }
  section ul, section ol { margin: 0 0 6px; padding-left: 18px; }
  section li { margin: 0 0 4px; font-size: 14px; }
  table { width: 100%; border-collapse: collapse; font-size: 13px; }
  th, td { border: 1px solid #e5e7eb; padding: 8px; text-align: left; vertical-align: top; }
  th { background: #f9fafb; font-size: 12px; text-transform: uppercase; letter-spacing: 0.4px; color: #4b5563; }
  td a { color: #9b9b94; text-decoration: none; }
  td a:hover { color: #6b6b64; text-decoration: underline; }
  .muted { color: #6b7280; font-size: 12px; margin-top: 8px; }
  .problem-box { background: #f9fafb; border-left: 3px solid #2563eb; padding: 12px; border-radius: 0 6px 6px 0; }
  .problem-box p { margin: 0 0 4px; font-size: 14px; }
  .problem-box .label { font-weight: 600; color: #374151; }
  @media (max-width: 800px) {
    table, thead, tbody, th, td, tr { display: block; }
    thead { display: none; }
    tr { margin-bottom: 10px; border: 1px solid #e5e7eb; }
    td { border: none; border-bottom: 1px solid #f3f4f6; }
    td:last-child { border-bottom: none; }
  }
</style>
</head>
<body>
<div class="container">
  <div class="nav">
    <a href="../go_now_lab_packets.html">All lab packets</a>
    <a href="../viewer.html">Assessment viewer</a>
    <a href="opc-go-002.html">&larr; Previous</a>
    <a href="opc-go-004.html">Next &rarr;</a>
  </div>

  <p class="muted">opc-go-003</p>
  <h1>CRISPR-Based Enhancement of Transformation Competence in Recalcitrant Elite Maize Lines</h1>
  <div class="meta">
    <span class="tag tag-go">READY TO TEST</span>
    <span class="tag tag-score">Score 0.527</span>
    <span class="tag tag-cost">$35,000 &ndash; $55,000</span>
  </div>

  <section>
    <h2>Problem mapping</h2>
    <div class="problem-box">
      <p><span class="label">Problem:</span> Genotype-specific transformation efficiency differences are driven by unknown underlying genetic or epigenetic variation, preventing widespread adoption of plant engineering in non-elite lines.</p>
      <p><span class="label">Sub-question:</span> Can identified genetic or epigenetic determinants of transformation competence be edited to convert recalcitrant elite lines into transformable lines?</p>
    </div>
  </section>

  <section>
    <h2>Objective</h2>
    <p>To determine if CRISPR/Cas9 editing of candidate transformation competence loci (BABY BOOM, WUSCHEL2, GRF-GIF) can increase Agrobacterium-mediated transformation efficiency in recalcitrant elite maize inbreds by at least 5-fold.</p>
  </section>

  <section>
    <h2>Readouts</h2>
    <ul><li>Primary: Transformation efficiency measured as percentage of regenerated T0 transgenic plants per inoculated immature embryo across three independent experiments</li><li>Secondary: Transgene integration events per line assessed by Southern blot and qPCR to confirm stable transformation</li><li>Secondary: Heritability of transformation competence in T1 and T2 generations measured by repeated transformation assays using edited line embryos</li></ul>
  </section>

  <section>
    <h2>Experimental design</h2>
    <p><strong>Overview:</strong> Edit BBM, WUS2, and GRF5-GIF1 loci in recalcitrant elite maize line B104 using CRISPR/Cas9 to create gain-of-function or overexpression alleles, then compare Agrobacterium-mediated transformation efficiency between edited and parental lines across multiple generations.</p>
    <ul><li>WP1: Design and validate CRISPR constructs targeting BBM, WUS2, and GRF5-GIF1 promoter regions to create constitutive or enhanced expression alleles; transform into Hi-II (transformable control line) for validation (Weeks 1-8)</li><li>WP2: Transform B104 elite recalcitrant line with validated CRISPR constructs; select and sequence T0 edited events; advance to T1 generation and confirm edits are heritable; backcross to remove Cas9 if necessary (Weeks 9-32)</li><li>WP3: Conduct standardized transformation efficiency assays on edited B104 lines and wild-type B104 using Agrobacterium strain EHA105 carrying pPHP71539 (bar + uidA); score transformation frequency, regeneration rate, and stable integration (Weeks 33-48)</li><li>WP4: Validate transformation competence heritability in T2 generation; perform molecular characterization of integration sites; statistical analysis comparing transformation rates across genotypes with ANOVA and post-hoc tests (Weeks 49-52)</li></ul>
    <p><strong>Controls:</strong></p>
    <ul><li>Positive control: Hi-II maize line transformed in parallel to validate Agrobacterium competence and media conditions (expected efficiency 15-30%)</li><li>Negative control: Wild-type B104 line without editing transformed in parallel (expected efficiency &lt;1%)</li><li>Mock control: B104 line transformed with empty vector CRISPR construct (no gRNA) to control for transformation procedure effects</li><li>Segregation control: T1 null segregants (non-edited siblings) from edited lines to control for genetic background effects</li></ul>
    <p><strong>Sample size plan:</strong> N=3 independent CRISPR constructs per target gene (9 total); minimum 5 independent T0 edited events advanced per construct; transformation efficiency assays with n=200 immature embryos per genotype per replicate across 3 biological replicates (total 600 embryos/genotype); statistical power calculation targets 80% power to detect 5-fold change at α=0.05</p>
    <p><strong>Success criteria:</strong></p>
    <ul><li>At least one edited line achieves ≥5-fold increase in transformation efficiency compared to wild-type B104 (e.g., from 0.5% to ≥2.5%) with p&lt;0.05 by one-way ANOVA</li><li>Enhanced transformation competence is heritable and stable through T2 generation with &lt;20% reduction in efficiency compared to T0 edited line</li><li>Edited lines show no major agronomic penalties: germination rate &gt;85%, plant height within 15% of wild-type, and normal seed set (&gt;80% of wild-type)</li></ul>
    <p><strong>Estimated timeline:</strong> 52 weeks</p>
  </section>

  <section>
    <h2>Materials</h2>
    <table>
      <thead><tr><th>Item</th><th>Supplier</th><th>Catalog / ID</th><th>Link</th><th>Purpose</th></tr></thead>
      <tbody><tr>
          <td>pYPQ146 Gateway-compatible Cas9 vector for maize</td>
          <td>Addgene</td>
          <td>164544</td>
          <td><a href="https://www.addgene.org/164544/" target="_blank" rel="noopener">source</a></td>
          <td>CRISPR/Cas9 delivery vector with maize-optimized expression cassettes</td>
        </tr><tr>
          <td>GoldenGate MoClo Plant Parts Kit</td>
          <td>Addgene</td>
          <td>1000000044</td>
          <td></td>
          <td>Modular cloning system for assembling gRNA expression cassettes</td>
        </tr><tr>
          <td>Agrobacterium tumefaciens EHA105 competent cells</td>
          <td>Teknova</td>
          <td>A1202</td>
          <td></td>
          <td>Agrobacterium strain for maize transformation</td>
        </tr><tr>
          <td>pPHP71539 binary vector (bar + uidA)</td>
          <td>John Innes Centre</td>
          <td>Request from ABRC stock center</td>
          <td><a href="https://abrc.osu.edu/" target="_blank" rel="noopener">source</a></td>
          <td>Standard transformation reporter construct for efficiency assays</td>
        </tr><tr>
          <td>Bialaphos (phosphinothricin, PPT)</td>
          <td>Gold Biotechnology</td>
          <td>B-110</td>
          <td></td>
          <td>Selection agent for bar-expressing transformants</td>
        </tr><tr>
          <td>N6 Basal Medium with Vitamins</td>
          <td>PhytoTechnology Laboratories</td>
          <td>N611</td>
          <td></td>
          <td>Base medium for maize tissue culture and regeneration</td>
        </tr><tr>
          <td>2,4-Dichlorophenoxyacetic acid (2,4-D)</td>
          <td>Sigma-Aldrich</td>
          <td>D7299</td>
          <td><a href="https://www.sigmaaldrich.com/catalog/product/sigma/d7299" target="_blank" rel="noopener">source</a></td>
          <td>Auxin for callus induction from immature embryos</td>
        </tr><tr>
          <td>DIG High Prime DNA Labeling and Detection Starter Kit II</td>
          <td>Roche</td>
          <td>11585614910</td>
          <td><a href="https://www.sigmaaldrich.com/catalog/product/roche/11585614910" target="_blank" rel="noopener">source</a></td>
          <td>Southern blot analysis to confirm transgene integration</td>
        </tr><tr>
          <td>GUS Histochemical Staining Kit</td>
          <td>Sigma-Aldrich</td>
          <td>GUSB-1KT</td>
          <td><a href="https://www.sigmaaldrich.com/catalog/product/sigma/gusb1kt" target="_blank" rel="noopener">source</a></td>
          <td>Visual detection of uidA expression in putative transformants</td>
        </tr><tr>
          <td>Phire Plant Direct PCR Kit</td>
          <td>Thermo Fisher Scientific</td>
          <td>F130WH</td>
          <td><a href="https://www.thermofisher.com/order/catalog/product/F130WH" target="_blank" rel="noopener">source</a></td>
          <td>Rapid genotyping of edited events and transgene presence</td>
        </tr><tr>
          <td>Alt-R CRISPR-Cas9 crRNA synthesis</td>
          <td>Integrated DNA Technologies</td>
          <td>Custom order</td>
          <td><a href="https://www.idtdna.com/pages/products/crispr-genome-editing/alt-r-crispr-cas9-system" target="_blank" rel="noopener">source</a></td>
          <td>Design validation: in vitro testing of gRNA efficiency before cloning</td>
        </tr><tr>
          <td>Percival AR-95L growth chamber</td>
          <td>Percival Scientific</td>
          <td>AR-95L</td>
          <td></td>
          <td>Controlled environment for regenerating transformants and growing edited lines</td>
        </tr></tbody>
    </table>
    <p class="muted">Direct cost estimate: $35,000 &ndash; $55,000 (Includes molecular biology reagents, tissue culture supplies, sequencing costs (~$8K), growth chamber space rental, and seed production. Excludes personnel costs, equipment already available (PCR machines, incubators, microscopes), greenhouse rental for backcrossing, and long-term generation advancement costs beyond T2)</p>
  </section>

  <section>
    <h2>References</h2>
    <ul><li>Lowe, K. et al. (2016) Morphogenic Regulators Baby boom and Wuschel Improve Monocot Transformation. Plant Cell 28:1998-2015 &mdash; Provides validated BBM and WUS2 expression strategies shown to enhance transformation; will adapt promoter and expression level strategies from this seminal work</li><li>Debernardi, J.M. et al. (2020) A GRF-GIF chimeric protein improves the regeneration efficiency of transgenic plants. Nature Biotechnology 38:1274-1279 &mdash; Describes GRF5-GIF1 chimeric construct design that enhances regeneration capacity; will create similar constructs or activation of endogenous loci</li><li>Frame, B.R. et al. (2011) Agrobacterium tumefaciens-mediated transformation of maize embryos using a standard binary vector system. Methods Mol Biol 710:327-341 &mdash; Standard protocol for maize transformation efficiency assays; will use this as basis for standardized comparative testing of edited vs. wild-type lines</li><li>Svitashev, S. et al. (2016) Genome editing in maize directed by CRISPR-Cas9 ribonucleoprotein complexes. Nature Communications 7:13274 &mdash; Maize CRISPR methodology including delivery methods, selection strategies, and confirmation of edits; informs construct design parameters</li><li>Char, S.N. et al. (2017) An Agrobacterium-delivered CRISPR/Cas9 system for high-frequency targeted mutagenesis in maize. Plant Biotechnology Journal 15:257-268 &mdash; Validates Agrobacterium delivery of CRISPR reagents in maize; provides technical details for combining transformation and editing in single step</li></ul>
  </section>

  <section>
    <h2>Lab handoff checklist</h2>
    <ul><li>Validated sequence information for BBM, WUS2, and GRF5-GIF1 loci in B104 background including 5kb upstream promoter regions and full-length CDS obtained through genome sequencing or PCR amplification and Sanger sequencing</li><li>Fresh immature embryo source: maintained B104 and Hi-II nursery plantings with staggered planting dates to ensure continuous supply of 10-14 DAP embryos throughout transformation experiments (minimum 20 donor ears per experiment)</li><li>Completed CRISPR gRNA design with in silico off-target analysis for B104 genome; minimum 3 gRNA candidates per target locus scoring &lt;3 predicted off-targets and &gt;70% predicted efficiency by CRISPOR or comparable tool</li><li>Institutional biosafety and field release approvals for generating and testing CRISPR-edited maize lines; USDA-APHIS regulatory determination if advancing edited lines to field testing</li><li>Baseline transformation efficiency data: at least one pilot transformation experiment completed on wild-type B104 and Hi-II to establish baseline rates and validate tissue culture competency of laboratory (minimum n=100 embryos per line)</li></ul>
  </section>

  <div class="nav" style="margin-top: 20px;">
    <a href="opc-go-002.html">&larr; Previous</a>
    <a href="../go_now_lab_packets.html">All lab packets</a>
    <a href="opc-go-004.html">Next &rarr;</a>
  </div>
</div>
</body>
</html>
